Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders.

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

"At one point, I looked like an alien, my face was completely red," Charlie, who is an author as well, told PA Real Life.

Dr. Jan Peter Dank, MD, Dermatologist, discusses What is Psoriasis? and How Does it Effect You. Trump admin. intends to move Greenland from U.S. European Command ...

A higher intake of riboflavin was associated with a reduced risk of developing psoriasis, but no other single vitamin associations were observed.

Scalp psoriasis can run the gamut from mild ... particularly in expanding access to youths and seniors. He previously served as an artist instructor for the Rockaway Artists Alliance, a ...

An expert in hair and scalp health who works with clients from across the UK has opened her flagship clinic in Derby.

A new King’s College London study links abdominal fat—not general obesity—to increased psoriasis risk, especially in women, ...

BELLY fat increases your risk of the skin condition psoriasis, a study warns. Psoriasis, which affects one in 50 people – ...

Scalp psoriasis poses unique challenges for people of color, including misdiagnosis, treatment access barriers, and lack of representation in medical education. Dr. Mona Shahriari, the senior editor ...

Arcutis Biotherapeutics has received FDA approval for ZORYVE (roflumilast) topical foam 0.3%, which is now available for treating plaque psoriasis on the scalp and body in patients aged 12 and older.